These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26395592)

  • 1. EUROmediCAT: Safety of Medication Use in Pregnancy.
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():1-2. PubMed ID: 26395592
    [No Abstract]   [Full Text] [Related]  

  • 2. EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy.
    EUROmediCAT Steering Group
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():3-7. PubMed ID: 26395593
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs in pregnancy--the issues for 2010.
    Davis DB
    J Popul Ther Clin Pharmacol; 2010; 17(3):e332-5. PubMed ID: 21041865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collection and analysis of drug safety data in pregnancy.
    Moretti M
    Can J Clin Pharmacol; 2007; 14(1):e34-6. PubMed ID: 17213508
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacovigilance activities in Nepal.
    Palaian S; Mohamed Ibrahim MI; Mishra P; Alam K; Shankar PR; Thapa BB
    Drug Saf; 2010 Oct; 33(10):889-90. PubMed ID: 20812773
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abuse-related adverse drug reactions and abuse deterrent formulations].
    Papaseit E; Pérez-Mañá C; Torrens M; Farré M
    Med Clin (Barc); 2013 Nov; 141(10):454-8. PubMed ID: 24144061
    [No Abstract]   [Full Text] [Related]  

  • 7. What do stakeholders think about pharmacovigilance?
    Edwards IR; Graedon T
    Drug Saf; 2010 Aug; 33(8):619-21. PubMed ID: 20635819
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug events and near misses: who's counting?
    Wu AW
    Am J Med; 2000 Aug; 109(2):166-8. PubMed ID: 10967161
    [No Abstract]   [Full Text] [Related]  

  • 10. International monitoring for adverse drug reactions of long latency.
    Fletcher AP; Griffin JP
    Adverse Drug React Toxicol Rev; 1991; 10(4):209-30. PubMed ID: 1793771
    [No Abstract]   [Full Text] [Related]  

  • 11. Electronic Reporting for Clinical Drug Safety and Pharmacovigilance. 29 - 30 October 2002, Amsterdam, The Netherlands.
    Hennig R
    Expert Opin Drug Saf; 2003 Mar; 2(2):195-7. PubMed ID: 12904118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Farmacovigilance: the way towards a safer drug use].
    Dobrić S
    Vojnosanit Pregl; 2007 Apr; 64(4):229-30. PubMed ID: 17580530
    [No Abstract]   [Full Text] [Related]  

  • 13. Two UK Government proposals bearing on drug safety.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1997 Mar; 16(1):1-7. PubMed ID: 9192053
    [No Abstract]   [Full Text] [Related]  

  • 14. How should we react to adverse drug reactions?
    Ferner RE; Beard K
    Postgrad Med J; 2011 Feb; 87(1024):81-2. PubMed ID: 21303818
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic ineffectiveness: heads or tails?
    Figueras A; Pedrós C; Valsecia M; Laporte JR
    Drug Saf; 2002; 25(7):485-7. PubMed ID: 12093306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European drug agency criticises Roche for failing to report adverse reactions and patient deaths.
    Wise J
    BMJ; 2012 Jun; 344():e4344. PubMed ID: 22736470
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug use during pregnancy: are risk classifications more dangerous than the drugs?
    Bianca S
    Lancet; 2003 Jul; 362(9380):329. PubMed ID: 12892970
    [No Abstract]   [Full Text] [Related]  

  • 18. An underrecognized challenge in evaluating postmarketing drug safety.
    Roden DM
    Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
    [No Abstract]   [Full Text] [Related]  

  • 19. The new EU legislation on pharmacovigilance and changing models for drug development.
    Callréus T
    Drug Saf; 2011 Jun; 34(6):529-30; author reply 530-1. PubMed ID: 21585224
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory agencies, pharmaceutical information and the Internet: a European perspective.
    Bauschke R
    Health Policy; 2012 Jan; 104(1):12-8. PubMed ID: 22101089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.